iSpecimen Inc.

About iSpecimen Inc.

iSpecimen connects life science researchers with human biospecimens from a diverse, global network of healthcare organizations and sample providers. Their mission is to streamline specimen procurement and bring innovation to the biospecimen industry by facilitating access to millions of specimens through their online Marketplace, reducing search time and supporting critical research.

Products & Services

Human Biospecimens:Offers a range of biospecimens including diagnostic remnants, banked, and prospective collections tailored to research needs.

Biofluids:Includes various blood and non-blood biofluids like whole blood, serum, plasma, urine, saliva, and more, with accompanying clinical data.

Tissue Samples:Provides access to a variety of tissue samples across disease states, many with clinical and molecular annotations.

Stem and Immune Cells:Offers banked and prospectively collected hematological tissues such as leukopaks, PBMCs, and bone marrow aspirate with customizable donor attributes.

Matched Sets:Provides matched sample sets of tissue, blood, and other biofluids for research consistency.

DNA & RNA Sequenced Cancer Tissue:Access to pre-screened cancer tumor tissues characterized by next-generation sequencing for specific mutations.

Specimen Procurement Services:Transforms biospecimen matchmaking to shorten R&D timelines for researchers.

iSpecimen Marketplace:An online platform connecting researchers to millions of biospecimens globally, ensuring quick and compliant access.

Specialties

Human Biospecimen Procurement Biospecimen Matchmaking Biofluids and Tissue Samples Stem and Immune Cells Cancer Research Specimens Disease-Specific Biospecimens (e.g., COVID-19, Oncology, Autoimmune)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 2500000 MR: - FA: $2.5 million FAN: 2500000	D: 2026-05-12 FD: 2026-05-12	-
2	RT: Private Placement T: - FT: Private Placement	A: 2500000 MR: - FA: approximately $2.5 million FAN: 2500000	D: 2026-05-08 FD: 2026-05-08	-
3	RT: Private Placement T: - FT: Private Placement	A: 5500000 MR: - FA: approximately $5.5 million FAN: 5500000	D: 2026-01-06 FD: 2026-01-06	-
4	RT: Private Placement T: - FT: Private Placement	A: 5500000 MR: - FA: approximately $5.5 million FAN: 5500000	D: 2025-12-30 FD: 2025-12-30	-
5	RT: Private Placement T: - FT: Private Placement	A: 1750000 MR: - FA: approximately $1.75 million FAN: 1750000	D: 2025-08-04 FD: 2025-08-04	-
6	RT: Private Placement T: - FT: Private Placement	A: 1750000 MR: - FA: approximately $1.75 million FAN: 1750000	D: 2025-07-31 FD: 2025-07-31	-
7	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 4000000 MR: - FA: approximately $4 million FAN: 4000000	D: 2025-07-28 FD: 2025-07-28	1 investors
8	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 4000000 MR: - FA: approximately $4 million FAN: 4000000	D: 2025-07-25 FD: 2025-07-25	1 investors
9	RT: Underwritten Public Offering T: - FT: Underwritten Public Offering	A: 4000000 MR: - FA: approximately $4 million FAN: 4000000	D: 2025-07-24 FD: 2025-07-24	1 investors
10	RT: Public Offering T: - FT: Public Offering	A: 5000000 MR: - FA: approximately $5 million FAN: 5000000	D: 2024-10-31 FD: 2024-10-31	-
11	RT: Public Offering T: - FT: Public Offering	A: 5000000 MR: - FA: approximately $5 million FAN: 5000000	D: 2024-10-30 FD: 2024-10-30	-

Private Placement Latest

2026-05-12

$2.5M

Private Placement 2026-05-08

$2.5M

Private Placement 2026-01-06

$5.5M

View 10 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Robert Lim

Chief Executive Officer

LinkedIn (Pro only)

K

Katharyn Field

Board Member

A

Avtar Dhaliwal

Board Member

Recent News

iSpecimen Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised